Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science Investigations

Correlation of Tumor and Whole-Body Dosimetry with Tumor Response and Toxicity in Refractory Neuroblastoma Treated with 131I-MIBG

Katherine K. Matthay, Colleen Panina, John Huberty, David Price, David V. Glidden, H. Roger Tang, Randall A. Hawkins, Janet Veatch and Bruce Hasegawa
Journal of Nuclear Medicine November 2001, 42 (11) 1713-1721;
Katherine K. Matthay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colleen Panina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Huberty
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Price
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David V. Glidden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Roger Tang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Randall A. Hawkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet Veatch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruce Hasegawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 11 1713-1721
PubMed 
11696644

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 1, 2001.

Copyright & Usage 
© 2001

Author Information

  1. Katherine K. Matthay,
  2. Colleen Panina,
  3. John Huberty,
  4. David Price,
  5. David V. Glidden,
  6. H. Roger Tang,
  7. Randall A. Hawkins,
  8. Janet Veatch and
  9. Bruce Hasegawa
  1. Departments of Pediatrics, Radiology, Epidemiology, and Biostatistics, University of California, San Francisco, San Francisco, California
View Full Text

Statistics from Altmetric.com

Cited By...

  • 130 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2001 to April 2025

AbstractFullPdf
Nov 2001696931
Dec 200115317
Jan 20026353
Feb 20023257
Mar 20028154
Apr 20025184
May 2002385
Jun 2002265
Jul 200215128
Aug 20023166
Sep 20026297
Oct 200262416
Nov 20028163
Dec 200221410
Jan 200343420
Feb 200381712
Mar 200371513
Apr 2003263
May 2003360
Jun 20034124
Jul 20037123
Aug 200312369
Sep 2003142713
Oct 200314328
Nov 200392313
Dec 200312227
Jan 200412164
Feb 200412215
Mar 200414204
Apr 200414114
May 2004404824
Jun 200447535
Jul 200437449
Aug 200442848
Sep 200424549
Oct 200423367
Nov 200416205
Dec 200433283
Jan 200514215
Feb 200524316
Mar 200526176
Apr 2005465
May 2005181011
Jun 20058448
Jul 20055148
Aug 200510207
Sep 20056258
Oct 200515147
Nov 200511119
Dec 20059106
Jan 20061089
Feb 2006987
Mar 200616710
Apr 2006833
May 2006638
Jun 2006936
Jul 20061086
Aug 20063810
Sep 200661818
Oct 200651814
Nov 20069167
Dec 2006111710
Jan 200752418
Feb 200721710
Mar 20074138
Apr 200711178
May 200751510
Jun 20073118
Jul 20077148
Aug 2007132218
Sep 200751510
Oct 2007132315
Nov 2007111724
Dec 200741713
Jan 20085239
Feb 200891719
Mar 200871517
Apr 200852418
May 20086186
Jun 200851114
Jul 200862514
Aug 200811164
Sep 200812177
Oct 20083129
Nov 20081159
Dec 2008878
Jan 20094175
Feb 2009101413
Mar 200961811
Apr 200951110
May 200971914
Jun 200931712
Jul 200922010
Aug 200942214
Sep 200952511
Oct 20094146
Nov 200981215
Dec 20091399
Jan 201091110
Feb 2010495
Mar 2010131919
Apr 20107189
May 201041714
Jun 2010587
Jul 2010677
Aug 2010374
Sep 201010614
Oct 201071110
Nov 20109116
Dec 2010777
Jan 20114156
Feb 201113136
Mar 201161610
Apr 20111169
May 201161112
Jun 201117129
Jul 201127714
Aug 2011111113
Sep 2011191214
Oct 20111357
Nov 201131712
Dec 201115137
Jan 201214119
Feb 201219106
Mar 2012231313
Apr 2012352516
May 2012251311
Jun 201220108
Jul 2012101011
Aug 2012161213
Sep 201223149
Oct 2012161114
Nov 2012452117
Dec 2012131510
Jan 2013311412
Feb 2013211917
Mar 2013281818
Apr 2013301412
May 2013432222
Jun 20131248
Jul 201318723
Aug 201327713
Sep 20131639
Oct 201312610
Nov 201316611
Dec 2013141212
Jan 201414712
Feb 201412927
Mar 20148919
Apr 2014141418
May 201412822
Jun 201416732
Jul 2014111331
Aug 201414955
Sep 2014251810
Oct 2014147917
Nov 201418579
Dec 2014175526
Jan 2015947
Feb 201514106
Mar 201527208
Apr 2015654
May 201516125
Jun 2015892
Jul 201515611
Aug 20151563
Sep 20152375
Oct 20151118
Nov 201519146
Dec 201526125
Jan 2016322221
Feb 201623816
Mar 201630310
Apr 201615612
May 201615415
Jun 201615128
Jul 20161377
Aug 2016588
Sep 201681011
Oct 20161795
Nov 201611713
Dec 20161486
Jan 20177209
Feb 20179187
Mar 2017685
Apr 20177125
May 20178114
Jun 201710168
Jul 201710142
Aug 20171254
Sep 2017520
Oct 201711312
Nov 20171229
Dec 20171077
Jan 20186112
Feb 201814712
Mar 201833511
Apr 201833710
May 201820516
Jun 20182169
Jul 201822810
Aug 20189110
Sep 201817010
Oct 201827415
Nov 201844922
Dec 201854113
Jan 201943724
Feb 201930417
Mar 201929713
Apr 201932216
May 20199510
Jun 2019819
Jul 2019141013
Aug 20199110
Sep 2019619
Oct 2019746
Nov 2019425
Dec 2019737
Jan 2020358
Feb 2020267
Mar 2020634
Apr 2020455
May 2020225
Jun 2020424
Jul 2020313
Aug 20206411
Sep 2020254
Oct 20201496
Nov 2020426
Dec 20201745
Jan 2021764
Feb 202151410
Mar 2021775
Apr 2021675
May 20214127
Jun 202111713
Jul 20218105
Aug 2021365
Sep 2021365
Oct 2021672
Nov 2021169
Dec 2021367
Jan 20229169
Feb 20222138
Mar 20222510
Apr 2022785
May 2022373
Jun 2022464
Jul 20225410
Aug 20226511
Sep 20220134
Oct 20220154
Nov 2022229
Dec 2022430
Jan 20236126
Feb 20230159
Mar 20234115
Apr 20234153
May 20235107
Jun 20232279
Jul 2023376
Aug 2023454
Sep 2023341
Oct 2023376
Nov 20237148
Dec 202316323
Jan 20240152
Feb 2024692
Mar 2024150
Apr 202461088
May 20242113
Jun 20241192
Jul 20243269
Aug 202414510
Sep 20242215
Oct 20243206
Nov 20242108
Dec 20241223
Jan 20254198
Feb 20253956
Mar 20255306
Apr 202574910
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 42, Issue 11
November 1, 2001
  • Table of Contents
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Correlation of Tumor and Whole-Body Dosimetry with Tumor Response and Toxicity in Refractory Neuroblastoma Treated with 131I-MIBG
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Correlation of Tumor and Whole-Body Dosimetry with Tumor Response and Toxicity in Refractory Neuroblastoma Treated with 131I-MIBG
Katherine K. Matthay, Colleen Panina, John Huberty, David Price, David V. Glidden, H. Roger Tang, Randall A. Hawkins, Janet Veatch, Bruce Hasegawa
Journal of Nuclear Medicine Nov 2001, 42 (11) 1713-1721;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Correlation of Tumor and Whole-Body Dosimetry with Tumor Response and Toxicity in Refractory Neuroblastoma Treated with 131I-MIBG
Katherine K. Matthay, Colleen Panina, John Huberty, David Price, David V. Glidden, H. Roger Tang, Randall A. Hawkins, Janet Veatch, Bruce Hasegawa
Journal of Nuclear Medicine Nov 2001, 42 (11) 1713-1721;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Rethinking Dosimetry: A European Perspective
  • Tumor Dose-Response Relationship of [131I]MIBG Therapy in Patients with Neural Crest Tumors by Means of [124I]MIBG PET
  • Theranostics for Neuroblastoma: Making Molecular Radiotherapy Work Better
  • Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice
  • Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
  • Norepinephrine Transporter as a Target for Imaging and Therapy
  • Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
  • Dose Escalation Study of No-Carrier-Added 131I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial
  • Promising Therapeutic Targets in Neuroblastoma
  • Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial
  • 131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose-Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling
  • Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma
  • Phase II Study of High-Dose [131I]Metaiodobenzylguanidine Therapy for Patients With Metastatic Pheochromocytoma and Paraganglioma
  • Iodine-131--Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study
  • Utility of Radiolabeled Somatostatin Receptor Analogues for Staging/Restaging and Treatment of Somatostatin Receptor-Positive Pediatric Tumors
  • A Transfectant Mosaic Xenograft Model for Evaluation of Targeted Radiotherapy in Combination with Gene Therapy In Vivo
  • Phase II Study on the Effect of Disease Sites, Age, and Prior Therapy on Response to Iodine-131-Metaiodobenzylguanidine Therapy in Refractory Neuroblastoma
  • Patient-Specific Dosimetry Calculations Using Mathematic Models of Different Anatomic Sizes During Therapy with 111In-DTPA-D-Phe1-Octreotide Infusions After Catheterization of the Hepatic Artery
  • Potential Increased Tumor-Dose Delivery with Combined 131I-MIBG and 90Y-DOTATOC Treatment in Neuroendocrine Tumors: A Theoretic Model
  • Phase I Dose Escalation of Iodine-131-Metaiodobenzylguanidine With Myeloablative Chemotherapy and Autologous Stem-Cell Transplantation in Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Consortium Study
  • Hematologic Toxicity of High-Dose Iodine-131-Metaiodobenzylguanidine Therapy for Advanced Neuroblastoma
  • Update on Hybrid Conjugate-View SPECT Tumor Dosimetry and Response in 131I-Tositumomab Therapy of Previously Untreated Lymphoma Patients
  • Total-Body and Red Marrow Dose Estimates
  • Google Scholar

More in this TOC Section

  • 11C-Methionine PET of Myocardial Inflammation in a Rat Model of Experimental Autoimmune Myocarditis
  • Counting Rate Characteristics and Image Distortion in Preclinical PET Imaging During Radiopharmaceutical Therapy
  • Design and Fabrication of Kidney Phantoms for Internal Radiation Dosimetry Using 3D Printing Technology
Show more Basic Science Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire